Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
The in vitro activity of ofloxacin (DL8280), a new pyridone carboxylic acid, against Chlamydia trachomatis serotype E was assessed by growth of chlamydia in cycloheximide-treated McCoy cells. Chlamydia-infected monolayers were exposed to the drug for 48 and 96 h and for 48 h followed by 48 h of further incubation after withdrawal of ofloxacin. Inclusions were visualized by indirect immunofluorescence, and the effect of the drug was assessed both by inclusion development and by the number of inclusion-forming units generated in the monolayers. The action of ofloxacin was completely lethal when monolayers were exposed to a concentration of 1 microgram/ml throughout one chlamydial developmental cycle. In contrast, tetracycline, when examined by similar techniques, inhibited inclusion development at a concentration of 0.3 micrograms/ml, but was only lethal at 2.4 micrograms/ml. Ofloxacin may prove to be a useful new antichlamydial agent.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002692:Chlamydia trachomatis / Q000187:drug effects*; D005455:Fluorescent Antibody Technique; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D010078:Oxazines; D015242:Ofloxacin; D013752:Tetracycline